Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Xin Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6784-4860; OpenAlex author ID A5027272944. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis. Co-author DOI 10.1016/j.lfs.2021.119505↗
  2. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling… Co-author DOI 10.3892/ol.2014.2711↗
  3. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradat… First author DOI 10.3892/or.2014.3266↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhangjian Zhou · 1 shared paper, 2021 · strength 0.12
  2. Yifan Cai · 1 shared paper, 2021 · strength 0.12
  3. Chengxue Dang · 1 shared paper, 2021 · strength 0.12
  4. Shuqun Zhang · 1 shared paper, 2021 · strength 0.12
  5. Min Tao · 2 shared papers, 2014–2015 · strength 0.09
  6. Yixiang Mao · 1 shared paper, 2015 · strength 0.05
  7. Daoming Li · 1 shared paper, 2015 · strength 0.05
  8. Weiming Duan · 1 shared paper, 2015 · strength 0.05
  9. Mengyao Wu · 1 shared paper, 2015 · strength 0.05
  10. Zekuan Xu · 1 shared paper, 2014 · strength 0.04
  11. Zheng Chen · 1 shared paper, 2014 · strength 0.04
  12. Wei Li · 1 shared paper, 2014 · strength 0.04
  13. Mengyao Wu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.